Patient Files: Familial Chylomicronaemia Syndrome

Dr Karishma Patel talks to PharmaTimes about the challenges of life with this ultra-rare genetic disorder

SmartPeople: Dr Gillian Burgess

On the comms radar

Pharma comms is one of the most dynamic  sectors of the industry. So, what should  be on communicators’ radar?

The biosimilars era

Biosimilars may have proven their worth, but how can adoption be sped up?

Company focus: Vasopharm

CEO Christian Wandersee explains the hurdles and hopes when developing drugs for traumatic brain injury, a devastating condition for which there is no existing drug treatment

Together as one

We caught up with IQVIA’s SVP global technology solutions, Tal Rosenberg, at the 2018 eyeforpharma Barcelona conference as the company announced the EU launch of its Orchestrated Customer Engagement product, which aims to harmonise pharma's interaction with customers

The ultimate cure?

Gene therapy still needs to overcome some major hurdles to truly fulfil its promise

Is trouble on the horizon for GSK?

Ana Nicholls asks whether GSK’s revenue drop is a short-term blip or a sign of bigger problems